Green Cross first acquires approval of tetanus & diphtheria vaccine in Korea
Green Cross has once again succeeded in localizing a basic vaccine.
On the 2nd, Green Cross(CEO Eun-Cheol Huh) announced it acquired product approval of the adult tetanus & diphtheria(TD) vaccine ‘Green Cross TD Vaccine Prefilled Syringe Inj’ from the Ministry of Food and Drug Safety on the 1st....
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
